Search results
Results from the WOW.Com Content Network
The four journals cover developments across the breadth of therapeutic areas and technologies relevant to the drug discovery and development pipeline. However, as of 2022, these titles have been discontinued and incorporated back into Drug Discovery Today. According to the Journal Citation Reports, the journal has a 2022 impact factor of 8.2. [1]
Drug Design, Development and Therapy; Drug Development and Industrial Pharmacy; Drug Discovery Today; Drug, Healthcare and Patient Safety; Drug Safety; Drug Metabolism Reviews; Drug Testing and Analysis; European Heart Journal - Cardiovascular Pharmacotherapy; European Journal of Pharmaceutical Sciences; European Journal of Pharmaceutics and ...
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science.
[65] The journal Drug Invention Today accepted an obviously bogus paper made up by Bohannon that should have been rejected by any good peer-review system. [66] Instead, Drug Invention Today was among many open-access journals that accepted the fake paper for publication. As of 2014, this journal had been transferred to a different publisher.
The Trends series was established in 1976 with Trends in Biochemical Sciences, rapidly followed by Trends in Neurosciences, Trends in Pharmacological Sciences, and Immunology Today. Immunology Today, Parasitology Today, and Molecular Medicine Today changed their names to Trends in... in 2001. Drug Discovery Today was spun off as an independent ...
Creating molecules GATC has its first drug invention awaiting FDA trials, Lam said. It's a potential breakthrough treatment for opioid use disorder. Another one, for PTSD treatment, is in the ...
Drugs is a peer-reviewed medical journal published by Adis International (Springer Nature) that covers topics in drugs and therapeutics. Besides research articles, the journal also publishes "Adis Drug Evaluations and AdisInsight Reports", evidence-based, single-agent reviews.
Inventiva SA (NASDAQ:IVA) stock traded higher on Monday, with a strong session volume of 8.55 million compared to an average volume of 9.91k, according to data from Benzinga Pro. The company ...